/BHST
BHST Stock - BioHarvest Sciences Inc. Common Stock
Basic Materials|Agricultural InputsNASDAQ
$5.23+0.19%
+$0.01 (+0.19%) • Dec 19
62
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.13
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.70
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+186.8%upside
Target: $15.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BHST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$5.18 – $5.28
TARGET (TP)$15.00
STOP LOSS$4.81
RISK/REWARD1:23.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.26
52W High$12.80
52W Low$4.72
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $25.19M | $12.67M | $5.50M | $2.10M | $396,000 |
| Gross Profit | $13.94M | $5.63M | $1.22M | $670,000 | $138,000 |
| Gross Margin | 55.4% | 44.5% | 22.2% | 31.9% | 34.8% |
| Operating Income | $-6,989,000 | $-9,966,000 | $-10,612,000 | $-8,491,000 | $-6,166,000 |
| Net Income | $-12,913,000 | $-12,564,000 | $-11,236,000 | $-9,827,000 | $-6,584,000 |
| Net Margin | -51.3% | -99.1% | -204.4% | -467.5% | -1662.6% |
| EPS | $-0.80 | $-0.93 | $-0.70 | $-0.70 | $-0.70 |
Company Overview
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
2
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
2 Bullish0 Neutral/Bearish
Price Targets
$14
Average Target
↑ 158.1% Upside
Now
$12
Low
$14
Average
$15
High
Based on 2 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| May 5th 2025 | Craig Hallum | Initiation | Buy | $15 |
| December 18th 2024 | Maxim Group | Initiation | Buy | $12 |
Earnings History & Surprises
BHSTBeat Rate
33%
Last 6 quarters
Avg Surprise
-37.8%
EPS vs Estimate
Beats / Misses
2/3
1 met exactly
Latest EPS
$-0.14
Q4 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q4 24
+58.0%
$-0.04vs$-0.10
Q4 24
-220.0%
$-0.16vs$-0.05
Q1 25
-41.7%
$-0.17vs$-0.12
Q2 25
+13.3%
$-0.13vs$-0.15
Q3 25
-36.4%
$-0.15vs$-0.11
Q4 25
0.0%
$-0.14vs$-0.14
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 30, 2026 | $-0.08 | — | — | — |
Q4 2025 | Nov 13, 2025 | $-0.14 | $-0.14 | 0.0% | = MET |
Q3 2025 | Aug 11, 2025 | $-0.11 | $-0.15 | -36.4% | ✗ MISS |
Q2 2025 | May 15, 2025 | $-0.15 | $-0.13 | +13.3% | ✓ BEAT |
Q1 2025 | Mar 31, 2025 | $-0.12 | $-0.17 | -41.7% | ✗ MISS |
Q4 2024 | Nov 25, 2024 | $-0.05 | $-0.16 | -220.0% | ✗ MISS |
Q4 2024 | Oct 23, 2024 | $-0.10 | $-0.04 | +58.0% | ✓ BEAT |
Q1 2024 | Mar 31, 2024 | — | $-0.48 | — | — |
Q4 2023 | Dec 31, 2023 | — | $-0.54 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.13 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.21 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.06 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.21 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.30 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.18 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.16 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.14 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.25 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.14 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.56 | — | — |
Latest News
BioHarvest Sciences Gets $1.6M Grant From Israeli Innovation Authority Under Bio-Convergence Program
📈 PositiveBenzinga•Dec 18, 2025, 12:37 PM•Also:
BioHarvest Sciences Rolls Out VINIA Blood Flow Hydration Solution In U.S.
📈 PositiveBenzinga•Dec 3, 2025, 12:33 PM•Also:
BioHarvest Sciences shares are trading lower after the company reported worse-than-expected Q3 financial results.
📉 NegativeBenzinga•Nov 13, 2025, 09:18 PM•Also:
BioHarvest Sciences Inc. - Common Stock Q3 EPS $(0.14) Misses $(0.12) Estimate, Sales $9.067M Miss $9.123M Estimate
📉 NegativeBenzinga•Nov 13, 2025, 09:04 PM•Also:
BioHarvest Sciences Prices 2,485,000 Shares Public Offering At $7/Share, Sees Gross Proceeds $17.4M
➖ NeutralBenzinga•Nov 7, 2025, 12:34 PM•Also:
BioHarvest Sciences announces proposed public offering; shares down
📉 NegativeSeeking Alpha•Nov 6, 2025, 10:43 PM•Also:
BioHarvest Sciences Announces Underwritten Public Offering; Terms Not Disclosed
➖ NeutralBenzinga•Nov 6, 2025, 09:55 PM•Also:
BioHarvest Enters Strategic CDMO Agreement With Saffron Tech To Revolutionize Global Saffron Production
📈 PositiveBenzinga•Oct 30, 2025, 11:45 AM•Also:
BioHarvest Raises $10.9M And Cuts $3.8M Debt In Major Balance Sheet Boost
📈 PositiveBenzinga•Sep 22, 2025, 10:36 AM•Also:
BioHarvest Produces Plant-Based Exosomes At Scale, Opening New Opportunities In Medicine And Skincare
📈 PositiveBenzinga•Sep 10, 2025, 11:03 AM•Also:
Bioharvest Sciences Files For Mixed Shelf Of Up To $100M
➖ NeutralBenzinga•Aug 28, 2025, 03:24 PM•Also:
Frequently Asked Questions about BHST
What is BHST's current stock price?
BioHarvest Sciences Inc. Common Stock (BHST) is currently trading at $5.23 per share. The stock has moved +0.19% today.
What is the analyst price target for BHST?
The average analyst price target for BHST is $15.00, based on 1 analyst.
What sector is BioHarvest Sciences Inc. Common Stock in?
BioHarvest Sciences Inc. Common Stock operates in the Basic Materials sector, specifically within the Agricultural Inputs industry. The company is traded on the NASDAQ exchange.
What is BHST's market cap?
BioHarvest Sciences Inc. Common Stock has a market capitalization of $0.09 billion, making it a small-cap company.
Does BHST pay dividends?
No, BioHarvest Sciences Inc. Common Stock does not currently pay a dividend to shareholders.
Similar Stocks
Basic Materials SectorACNT
Ascent Industries Co.
$15.66
Mkt Cap: $0.1B
AVD
American Vanguard Corporation
$3.89
Mkt Cap: $0.1B
BIOX
Bioceres Crop Solutions Corp.
$1.40
Mkt Cap: $0.1B
CMT
Core Molding Technologies, Inc.
$21.29
Mkt Cap: $0.2B
FF
FutureFuel Corp.
$3.41
Mkt Cap: $0.1B
FRD
Friedman Industries, Incorporated
$21.41
Mkt Cap: $0.2B
LVRO
Lavoro Limited
$0.61
Mkt Cap: $0.1B
MERC
Mercer International Inc.
$2.08
Mkt Cap: $0.1B
TRX
TRX Gold Corporation
$0.91
Mkt Cap: $0.3B
USGO
U.S. GoldMining Inc.
$9.76
Mkt Cap: $0.1B
Explore stocks similar to BHST for comparison